ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-04262
製品名称
B7-H3 Protein, Human, Recombinant (His), Biotinylated
タンパク質名
B7-H3
Species
Human
HOST
HEK293 Cells
20μg: -
お問い合わせ

Overview

Synonyms B7RP-2, CD276 molecule, B7H3, 4Ig-B7-H3, B7-H3
Characteristics Immobilized Anti-B7-H3 Antibody, IgG1 Kappa at 2 μg/mL (100 μL/well) can bind Recombinant Human CD276 / B7-H3 Protein (His Tag), Biotinylated , the EC50 is 3.6-12 ng/mL.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 96.60%
Description B7-H3 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 48 kDa and the accession number is Q5ZPR3-1.
Reference Sun J,et al.(2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother. 59(8): 1163-71.,Waschbisch A,et al.(2008) Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions. Arthritis Rheum. 58(11): 3600-8.,Loos M,et al.(2010) B7-h3 and its role in antitumor immunity. Clin Dev Immunol. 2010: 683875.,Suh WK,et al.(2004) The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci U S A. 101(35): 12969-73.,Zang X,et al.(2010) Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol. 23(8): 1104-12.
URL https://www.targetmol.com/recombinant-protein/b7_h3_protein_human_recombinant_his_tag_biotinylated

お問い合わせリスト(-)

お問い合わせフォーム